K182535 is an FDA 510(k) clearance for the R3 Anteverted Liners. This device is classified as a Prosthesis, Hip, Semi-constrained, Uncemented, Metal/polymer, Porous (Class II - Special Controls, product code MBL).
Submitted by Smith & Nephew, Inc. (Memphis, US). The FDA issued a Cleared decision on November 19, 2018, 66 days after receiving the submission on September 14, 2018.
This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3358.
| 510(k) Number | K182535 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | September 14, 2018 |
| Decision Date | November 19, 2018 |
| Days to Decision | 66 days |
| Submission Type | Special |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | MBL — Prosthesis, Hip, Semi-constrained, Uncemented, Metal/polymer, Porous |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 888.3358 |